The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
News-Medical.Net on MSN
Gene therapy breakthrough could provide hope for millions living with chronic pain
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
Pain-sensing neurons in the gut kindle inflammatory immune responses that cause allergies and asthma, according to a new ...
The field of epilepsy research has rapidly evolved with an appreciation that seizures arise from dysfunctions in distributed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback